Serum metabolomics indicates ferroptosis in patients with pantothenate kinase associated neurodegeneration
Abstract The core syndrome among NBIA disorders is pantothenate kinase-associated neurodegeneration (PKAN), an autosomal recessive disorder caused by mutations in the PANK2 gene. There is no therapy for PKAN; only symptomatic treatment is available. Our work aimed to identify the mechanisms induced...
Saved in:
| Main Authors: | Beata Toczylowska, Marta Skowronska, Iwona Kurkowska-Jastrzebska, Anna Ruszczynska, Elzbieta Zieminska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-94838-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathology and treatment methods in pantothenate kinase-associated neurodegeneration
by: Robert Kwinta, et al.
Published: (2024-07-01) -
Uncovering exposome-related diseases through the pathologic metallome: a novel approach for clinical populations
by: Riccardo Leinardi, et al.
Published: (2025-08-01) -
Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration
by: Daniel I Orellana, et al.
Published: (2016-08-01) -
Retinitis pigmentosa in pantothenate kinase-associated neurodegeneration
by: José Luiz Pedroso, et al.
Published: (2014-10-01) -
PANK activators for the treatment of pantothenate kinase-associated neurodegeneration
by: Jessica Regan, Ph.D., et al.
Published: (2025-07-01)